Please assess the completion status of the following clinical trial:

Trial Title: Pharmacogenomics of Antiplatelet Response

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 45-75 years~* GeneSTAR participant~* No personal History of Coronary Artery Disease~* Women who are post-menopausal~* Women who are using a reliable method of contraception, such as history of tubal ligation, IUD or taking OCP~Exclusion Criteria:~* Taking aspirin prescribed by physician~* weight \< 60 kg~* History of recent or current bleeding~* allergy to aspirin or history of adverse events to aspirin~* serious comorbid conditions (such as AIDS, active cancer)~* high blood pressure (\>160/95)~* History of gastrointestinal ulcer/bleeding~* Mental incompetence to make decision to participate.

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Aspirin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).